| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.052 | 0.8 |